Moderate Emetic Risk Intravenous Antineoplastic Agent

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.1444.5.243
Version
20220910
PublisherAmerican Society of Clinical Oncology StewardDate2022-09-10T01:02:30-04:00Purpose

(Clinical Focus: The purpose of this value set is to represent concepts of moderate emetic risk intravenous antineoplastic agent.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a moderate emetic risk intravenous antineoplastic medication; generic; prescribable; injectable.),(Exclusion Criteria: Excludes concepts that represent non-prescribable branded drugs, components or ingredients.)

Expansion
<<>>>
CodeDisplaySystem
309650http://www.nlm.nih.gov/research/umls/rxnorm
2002002http://www.nlm.nih.gov/research/umls/rxnorm
1191138http://www.nlm.nih.gov/research/umls/rxnorm
1790103http://www.nlm.nih.gov/research/umls/rxnorm
1790099http://www.nlm.nih.gov/research/umls/rxnorm
1790095http://www.nlm.nih.gov/research/umls/rxnorm
1790097http://www.nlm.nih.gov/research/umls/rxnorm
1790100http://www.nlm.nih.gov/research/umls/rxnorm
1872062http://www.nlm.nih.gov/research/umls/rxnorm
1732182http://www.nlm.nih.gov/research/umls/rxnorm
1732186http://www.nlm.nih.gov/research/umls/rxnorm
1791498http://www.nlm.nih.gov/research/umls/rxnorm
1791493http://www.nlm.nih.gov/research/umls/rxnorm
1791500http://www.nlm.nih.gov/research/umls/rxnorm
1726097http://www.nlm.nih.gov/research/umls/rxnorm
1726319http://www.nlm.nih.gov/research/umls/rxnorm
829926http://www.nlm.nih.gov/research/umls/rxnorm
1594658http://www.nlm.nih.gov/research/umls/rxnorm
1736784http://www.nlm.nih.gov/research/umls/rxnorm
1942743http://www.nlm.nih.gov/research/umls/rxnorm